Waste Generation in Pediatric Orthopaedic Hardware Removal Surgery

Tyler M Staten1, Wade E Quilter1, Brittany N Garcia2

  • 1Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA.

Insights

Pediatric hardware removal surgeries generate substantial waste, averaging 6.8 kg per case. Reducing this waste through better labeling and pack optimization can lower environmental and financial burdens.

Area of Science:

  • Orthopaedic Surgery
  • Environmental Health
  • Healthcare Waste Management

Background:

  • Hardware removal (ROH) is a common pediatric orthopaedic procedure.
  • Surgeons must weigh ROH benefits against risks, costs, and waste generation.
  • Understanding waste impact is crucial for patient and population health.

Purpose of the Study:

  • To quantify and characterize intraoperative waste from pediatric ROH surgery.
  • To identify key waste contributors and inform reduction strategies.
  • To assess the environmental and financial impact of pediatric ROH waste.

Main Methods:

  • Audit of 10 pediatric ROH cases at a tertiary care hospital.
  • Collection, categorization, and weighing of all intraoperative waste.
  • Classification of waste by usage (unused, used but not soiled, used and soiled) and labeling.

Main Results:

  • Average of 6.8 kg of solid waste generated per case (range 5.3–8.1 kg).
  • Drapes (1.2 kg) and hard plastics (1.14 kg) were major waste contributors.
  • Only 11% of plastic waste had recycling labels; 7.76 kg of waste was unused.

Conclusions:

  • Pediatric ROH generates significant waste, with potential national annual contribution exceeding 450,000 pounds.
  • Clearer recycling labels, optimized procedure packs, and reduced draping can decrease waste.
  • Balancing surgical benefits with waste reduction promotes high-value, sustainable care.
Abstract

Related Concept Videos

GIS Software, Hardware, and Sources of GIS Data01:23

GIS Software, Hardware, and Sources of GIS Data

A Geographic Information System (GIS) combines specialized software and hardware to effectively manage, analyze, and present spatial and related data. GIS software includes critical functionalities such as a user interface for easy navigation, database management tools for handling spatial and attribute data, and data retrieval features for efficient access. Analytical tools transform raw data into insights, while display functions produce maps and reports in various formats for effective...
763
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
203